Abstract:Aim: To investigate the role of immunogenetic factors in the pathogenesis of abnormal scars based on the research of the expression levels and distribution patterns of HLA-II (HLA-DR, -DQ, -DP) and CD1a molecules in peripheral blood mononuclear cells of patients with abnormal scar. Methods: The expression levels and distribution patterns of HLA-II (HLA-DR, -DQ, -DP) and CD1a molecules in peripheral blood mononuclear cells were determined in 10 samples of keloid, 10 samples of hypertrophic scar, 10 samples of thin and flat scar and 10 cases of normal people with immunocytohistochemical staining. Results: 1 The amounts of HLA-DR+, -DQ+, -DP+ and CD1a+ cells had no significant differences among the keloid, hypertrophic scar, thin and flat scar and normal people groups (P > 0.05). 2 The integrated absorbance of HLA-DR+ cell (813.16 ± 62.77, 883.11 ± 146.71; F = 10.613, P < 0.01), -DQ+ cell (420.12 ± 94.25, 439.24 ± 146.65; F = 5.143, P < 0.01), -DP± cell (259.40 ± 57.43, 271.93 ± 70.38; F = 9.177, P < 0.01) and CD1a+ cell (580.15 ± 108.48, 648.94 ± 185.46; F = 8.581, P < 0.01) molecules in the keloid and hypertrophic scar groups was higher respectively than that of HLA-DR+ (636.22 ± 133.95, 597.88 ± 166.36), -DQ(302.77 ± 89.77, 308.57 ± 44.05), -DP+(192.96 ± 51.32, 159.01 ± 31.99) and CD1a+ (423.53 ± 142.36, 368.67 ± 117.18) molecules in the thin and flat scar and normal people groups. This indicates that the contents of HLA-DR, -DQ, -DP and CD1a protein in the keloid and hypertrophic scar groups were was higher than those of thin and flat scar and normal people groups. Conclusion: The increased contents of HLA-DR, -DQ, -DP and CD1a protein in peripheral blood of patients with the keloid and hypertrophic scar suggest that the hyperplasia of scars may be associated with immunogenetic factors.

Correlation of serum levels of interleukin-4 and interferon-γ and scar formation in patients with acne vulgaris.

Investigation the Relations Between Serum Level of IL-18,1L-18BP and IFN-γin Severe Acne and the Pathogenesis Analysis

Study of interleukin-1 beta expression in acne vulgaris and acne scars

Comparisons of the Effects of Topical Anti-Scar Drugs on Post-Surgical Facial Scar Formation: a Clinical Investigation.

Assessment of Serum Interleukin-23 in Acne Vulgaris Patients and Its Correlation with Disease Severity

Assessment of Serum Interleukin-36γ Level in Patients with Acne Vulgaris and Post -Acne Scars

Relationship Between Serum Concentrations of IL-18, IL-10, IL-6 and Acute Coronary Syndrome

Association of serum interleukin-10 (IL-10) with the severity of acne vulgaris

Evaluation of serum levels of interleukins 1‐beta, 10 and 12 in patients with acne vulgaris

CORRELATION OF INTERLEUKIN-23 SERUM LEVELS IN MEN WITH ACNE VULGARIS: A PRELIMINARY STUDY

Evaluating the Role of Interleukin-36 and Interleukin-38 in Acne Vulgaris Patients

Correlation of serum Insulin-Like Growth Factor one with acne severity

The related factors of acne severity and acne scars

Evaluation of Interleukin-31 and C-reactive Protein in Inflammatory Acne Vulgaris Patients

Survivin and insulin-like growth factor-I: potential role in the pathogenesis of acne and post-acne scar

Levels of the proinflammatory cytokines: interleukin-8, interleukin-12, tumor necrosis factor-α in severe acne at makassar

DIFFERENCES IN INTERLEUKIN-23 SERUM LEVELS TOWARDS THE SEVERITY OF ACNE VULGARIS IN WOMEN

The pivotal role of inflammation in scar/keloid formation after acne

Immunogenetic regulation of HLA- Ⅱ type and CD1a positive cells in peripheral blood of patients with abnormal scar

Changes of IL-4, IL-10, IL-12, IL-13, IFN-γ and TGF-β in the serum of atopic dermatitis patients at different stages of the disease

Serum levels of hypersensitive-C-reactive protein in moderate and severe acne